期刊
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
卷 35, 期 -, 页码 114-123出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jddst.2016.06.009
关键词
Biomaterials; Nanometer; Patterning; Composite; Electrohydrodynamic; Antibiotic
资金
- National Nature Science Foundation of China [81301304]
- Key Technologies RAMP
- D Program of Zhejiang Province [2015C02035]
- Research Fund for The Doctoral Program of Higher Education of China [20130101120170]
The electrohydrodynamic atomization (EHDA) fabrication route for the preparation of polymeric biomaterials and drug delivery systems has gained extensive popularity over the last decade particularly for drug loaded particle (electrospraying) and fiber (electrospinning) morphologies. In this study, patterned micron scaled structures of polyvinyl pyrrolidone (PVP), polyethylene oxide (PEO) and tetracycline hydrochloride (TE-HCL, an antibiotic) composites were demonstrated via EHDA printing. A selection of patterns (parallel lines, grids and arcs) were generated indicating structure complexity potential. Printing parameters (such as collector speed, working distance and applied voltage) were assessed for their impact on fiber diameter. Linear polymer-drug composite fibers (similar to 700nm-5 mu m) were deposited using the EHDA printing technique providing precision deposition control - not demonstrated with conventional EHDA engineering platforms. Fourier-transform infrared spectroscopy (FTIR) analyses revealed PVP-PEO blend behavior and also the incorporation of the active into the polymeric matrix. The release of antibiotic from patterned structures was demonstrated over 5 h which is comparable to existing polymer based matrix systems. The printing of active-polymeric fibers provides an innovative approach to develop tailored pharmaceutical dosage forms (shape, size and formulation) with minimal excipients. It also provides patient driven dosage engineering which is beneficial for personalized medicines. Printed medications (via single step) have potential to reduce costs, improve patient compliance and lead to the development of personalized medicines. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据